PLGA-PEG-ZOL drug-loaded nano-material specifically targeting bone tissuse, and preparation method thereof
A PLGA-PEG-ZOL, drug-loaded nanotechnology, applied in the direction of pharmaceutical formula, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., can solve the problems of widespread use and delay the onset Burst-release dose, ease of handling, effects of increasing drug stability and solubility
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] A kind of PLGA-PEG-ZOL drug-loaded nanomaterial specifically targeting bone tissue of the present invention, such as figure 1 As shown, polylactic acid-glycolic acid is used as the matrix of drug-loaded nanomaterials, and zoledronic acid is coupled to the surface of the matrix; the chemical formula of PLGA-PEG-ZOL is Wherein, 5≤n≤100, 5≤x≤100, 5≤y≤100.
[0043] The preparation method of the PLGA-PEG-ZOL drug-loaded nanomaterial specifically targeting bone tissue in this embodiment comprises the following steps:
[0044] (1) With polylactic acid-glycolic acid (2g, 0.02mmol) and diaminopolyethylene glycol (0.8g, 0.04mmol) as substrates, dicyclohexylcarbodiimide (0.049g, 0.24mmol) and N -Hydroxysuccinimide (0.027g, 0.024mmol) is used as a dehydrating agent, and 100ml of toluene is used as a solvent. All the above-mentioned substances are added in a 250ml single-necked flask, and a water separator and a reflux condenser flask are connected to the flask. Heating to 140°C ...
Embodiment 2
[0061] A kind of PLGA-PEG-ZOL drug-loaded nanomaterial specifically targeting bone tissue of the present invention, such as figure 1 As shown, polylactic acid-glycolic acid is used as the matrix of drug-loaded nanomaterials, and zoledronic acid is coupled to the surface of the matrix; the chemical formula of PLGA-PEG-ZOL is Wherein, 5≤n≤100, 5≤x≤100, 5≤y≤100.
[0062] The preparation method of the PLGA-PEG-ZOL drug-loaded nanomaterial specifically targeting bone tissue in this embodiment comprises the following steps:
[0063] (1) With polylactic acid-glycolic acid (2g, 0.02mmol) and diaminopolyethylene glycol (1g, 0.05mmol) as substrates, dicyclohexylcarbodiimide (0.074g, 0.36mmol) and N- Hydroxysuccinimide (0.020g, 0.018mmol) is used as a dehydrating agent, and 150ml of toluene is used as a solvent. All the above-mentioned substances are added in a 250ml single-necked flask, and the water separator and the reflux condenser flask are connected to the flask, and heated The ...
Embodiment 3
[0067] A kind of PLGA-PEG-ZOL drug-loaded nanomaterial specifically targeting bone tissue of the present invention, such as figure 1 As shown, polylactic acid-glycolic acid is used as the matrix of drug-loaded nanomaterials, and zoledronic acid is coupled to the surface of the matrix; the chemical formula of PLGA-PEG-ZOL is Wherein, 5≤n≤100, 5≤x≤100, 5≤y≤100.
[0068] The preparation method of the PLGA-PEG-ZOL drug-loaded nanomaterial specifically targeting bone tissue in this embodiment comprises the following steps:
[0069](1) With polylactic acid-glycolic acid (2g, 0.02mmol) and diaminopolyethylene glycol (0.8g, 0.04mmol) as substrates, dicyclohexylcarbodiimide (0.061g, 0.3mmol) and N -Hydroxysuccinimide (0.022g, 0.02mmol) is used as a dehydrating agent, and 100ml of toluene is used as a solvent. All the above-mentioned substances are added in a 250ml single-necked flask, and a water separator and a reflux condenser flask are connected to the flask. Heating to 140°C for...
PUM
Property | Measurement | Unit |
---|---|---|
particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com